Table 1.
Characteristics of study participants.
| GPA Group (N- 14) |
Control Group (N- 20) |
|||
|---|---|---|---|---|
| Age, average ± SD | 47.2 ± 10.1 | 40.4 ± 9.2 | ||
| Sex | Female | 6 (42.9%) | 11 (55.0%) | |
| Male | 8 (57.1%) | 9 (45.0%) | ||
| Disease duration, years (range) | 2.8 (0.5–15) | - | ||
| ANCA-positive | 10 (71.4%) | - | ||
|
Medication usage (ever) |
Glucocorticoids | 14 (100%) | - | |
| Immunosuppressants | 13 (92.9%) | |||
| Biologicals | 4 (28.6%) | |||
|
Organ involvement (ever) |
Ear, nose, throat | 14 (100%) | - | |
| Lung | 10 (71.4%) | |||
| Kidney | 6 (42.9%) | |||
| Nervous system | 3 (21.4%) | |||
| Musculoskeletal system | 1 (7.1%) | |||
| Skin | 1 (7.1%) | |||
| Eye | 1 (7.1%) | |||